Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity
Saved in:
| Published in: | EPMA Journal |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity
- Beta-Glucan modulates monocyte plasticity and differentiation capacity to mitigate DSS-induced colitis
- PPM1G‒MET axis sustains AKT signaling to drive Twist‐associated EMT and drug resistance in hepatocellular carcinoma
- Cuproptosis: a novel mechanism and 3PM-oriented therapeutic strategy for cancer
- Enteropathogenic Escherichia coli-mediated fast and coordinated Ca²+ responses regulate NF-κB activation
- Serotonin as a psychosocial biomarker in 3PM psychiatry: from the social brain to personalised intervention
- PARP1 trapping activates ATM-mediated NF-κB signaling independent of replication in response to TOP1 blockade